Incyte to Present at the 34th Annual J. P. Morgan Healthcare Conference

WILMINGTON, Del.--()--Incyte Corporation (Nasdaq:INCY) announced today that it will present at the 34th Annual J. P. Morgan Healthcare Conference on Monday, January 11, 2016 at 1:30 p.m. PST (4:30 p.m. EST) in San Francisco.

The presentation will be webcast live and can be accessed within the Investors section of www.incyte.com under Events and Presentations. Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The slide deck and a replay of the presentation will also be made available following the presentation.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology. For additional information on Incyte, please visit the Company's web site at www.incyte.com.

Contacts

Incyte Corporation
Media
Catalina Loveman, +1 302-498-6171
cloveman@incyte.com
or
Investors
Michael Booth, DPhil. +1 302-498-5914
mbooth@incyte.com

Contacts

Incyte Corporation
Media
Catalina Loveman, +1 302-498-6171
cloveman@incyte.com
or
Investors
Michael Booth, DPhil. +1 302-498-5914
mbooth@incyte.com